Chemoinformaics analysis of des-N-Methylnoracronycine
Molecular Weight | 293.322 | nRot | 0 |
Heavy Atom Molecular Weight | 278.202 | nRig | 22 |
Exact Molecular Weight | 293.105 | nRing | 4 |
Solubility: LogS | -3.95 | nHRing | 2 |
Solubility: LogP | 4.071 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 14 |
No. of Oxygen atom | 3 | No. of Arom Bond | 16 |
nHA | 3 | APOL | 43.5679 |
nHD | 2 | BPOL | 18.2221 |
QED | 0.623 |
Synth | 2.813 |
Natural Product Likeliness | 2.097 |
NR-PPAR-gamma | 0.961 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.411 |
Pgp-sub | 0.001 |
HIA | 0.062 |
CACO-2 | -4.986 |
MDCK | 0.0000168 |
BBB | 0.119 |
PPB | 0.973733 |
VDSS | 0.449 |
FU | 0.0161802 |
CYP1A2-inh | 0.974 |
CYP1A2-sub | 0.768 |
CYP2c19-inh | 0.801 |
CYP2c19-sub | 0.102 |
CYP2c9-inh | 0.867 |
CYP2c9-sub | 0.92 |
CYP2d6-inh | 0.89 |
CYP2d6-sub | 0.775 |
CYP3a4-inh | 0.552 |
CYP3a4-sub | 0.18 |
CL | 1.871 |
T12 | 0.267 |
hERG | 0.04 |
Ames | 0.683 |
ROA | 0.973 |
SkinSen | 0.913 |
Carcinogencity | 0.897 |
EI | 0.91 |
Respiratory | 0.976 |
NR-Aromatase | 0.795 |
Antiviral | Yes |
Prediction | 0.782439 |